Summary
- Splice variants
- Transcript comparison
- Gene alleles
Sequence
- Secondary Structure
Comparative Genomics
Ontologies
- GO: Anatomical entity
Phenotypes
Genetic Variation
- Variant table
- Variant image
- Structural variants
Gene expression
Pathway
Molecular interactions
Regulation
External references
Supporting evidence
ID History
- Gene history

Configure this page

Share this page

Bookmark this page

.

Gene: PER2 ENSONIG00000007937

.

Description

period circadian regulator 2 [Source:UniProtKB Gene Name;Acc:A0A669AVE8]

Location

Primary_assembly LG14: 8,032,664-8,052,554 forward strand.

O_niloticus_UMD_NMBU:CM007495.2

About this gene

This gene has 6 transcripts (splice variants), 181 orthologues and 3 paralogues.

Transcripts

Show transcript tableHide transcript table

Transcript ID	Name	bp	Protein	Translation ID	Biotype	UniProt Match	Flags
ENSONIT00000082463.1	PER2-202	4775	1467aa	ENSONIP00000042032.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669C2M5	A single transcript chosen for a gene which is the most conserved, most highly expressed, has the longest coding sequence and is represented in other key resources, such as NCBI and UniProt. This is defined in detail on http://www.ensembl.org/info/genome/genebuild/canonical.htmlEnsembl Canonical,
ENSONIT00000055845.1	PER2-201	7020	1185aa	ENSONIP00000067782.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669EA06	-
ENSONIT00000010007.2	PER2-203	4088	1096aa	ENSONIP00000009999.2	Gene/transcipt that contains an open reading frame (ORF).Protein coding	I3JMA5	-
ENSONIT00000048033.1	PER2-204	4061	1087aa	ENSONIP00000027091.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669AVE8	-
ENSONIT00000075899.1	PER2-206	2190	527aa	ENSONIP00000056905.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669DEY1	-
ENSONIT00000059445.1	PER2-205	2147	449aa	ENSONIP00000031800.1	Gene/transcipt that contains an open reading frame (ORF).Protein coding	A0A669BBH5	-

.

Summary

.

.